Lyn
In rereading my post on
Erbitux, I realized that I was not clear that for 95% of oral cancer patients,
Erbitux is a really good decision. Unquestionably, both the Bonner and the Extreme trials indicate that
Erbitux is an effective treatment for most oral cancer patients. Unfortunately I was part of the 5% of oral cancer patients for whom
Erbitux just does not work at all due to genetics (it also does not work for 40% of colorectal cancer patients but they have a test to determine who's who for them but not for us). So it's almost certain that you will have good results from the trial. It is important that the trials do get enough
Erbitux patients to finally settle the question if it is as good or better than platinum. Hey, when the weatherman says there is a 95% chance of sunshine and only 5% of rain, nobody packs an umbrella. I apologize in advance if my biased comments last night caused you any worries. You will be fine
Charm